Literature DB >> 17292863

AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36.

Daphna D J Habets1, Will A Coumans, Peter J Voshol, Marion A M den Boer, Maria Febbraio, Arend Bonen, Jan F C Glatz, Joost J F P Luiken.   

Abstract

CD36, also named fatty acid translocase, has been identified as a putative membrane transporter for long-chain fatty acids (LCFA). In the heart, contraction-induced 5' AMP-activated protein kinase (AMPK) signaling regulates cellular LCFA uptake through translocation of CD36 and possibly of other LCFA transporters from intracellular storage compartments to the sarcolemma. In this study, isolated cardiomyocytes from CD36(+/+)- and CD36(-/-) mice were used to investigate to what extent basal and AMPK-mediated LCFA uptake are CD36-dependent. Basal LCFA uptake was not altered in CD36(-/-) cardiomyocytes, most likely resulting from a (1.8-fold) compensatory upregulation of fatty acid-transport protein-1. The stimulatory effect of contraction-mimetic stimuli, oligomycin (2.5-fold) and dipyridamole (1.6-fold), on LCFA uptake into CD36(+/+) cardiomyocytes was almost completely lost in CD36(-/-) cardiomyocytes, despite that AMPK signaling was fully intact. CD36 is almost entirely responsible for AMPK-mediated stimulation of LCFA uptake in cardiomyocytes, indicating a pivotal role for CD36 in mediating changes in cardiac LCFA fluxes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292863     DOI: 10.1016/j.bbrc.2007.01.141

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

Review 1.  Clinical Spectrum of PRKAG2 Syndrome.

Authors:  Andrea Giuseppe Porto; Francesca Brun; Giovanni Maria Severini; Pasquale Losurdo; Enrico Fabris; Matthew R G Taylor; Luisa Mestroni; Gianfranco Sinagra
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-01

Review 2.  Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization.

Authors:  Jan F C Glatz; Joost J F P Luiken
Journal:  J Lipid Res       Date:  2018-04-07       Impact factor: 5.922

3.  Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis.

Authors:  Thi Thu Trang Tran; Hélène Poirier; Lionel Clément; Fatiha Nassir; Maurice M A L Pelsers; Valérie Petit; Pascal Degrace; Marie-Claude Monnot; Jan F C Glatz; Nada A Abumrad; Philippe Besnard; Isabelle Niot
Journal:  J Biol Chem       Date:  2011-05-24       Impact factor: 5.157

4.  FAT/CD36 is localized in sarcolemma and in vesicle-like structures in subsarcolemma regions but not in mitochondria.

Authors:  Jacob Jeppesen; Martin Mogensen; Clara Prats; Kent Sahlin; Klavs Madsen; Bente Kiens
Journal:  J Lipid Res       Date:  2009-12-18       Impact factor: 5.922

5.  Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart.

Authors:  Ji Li; Dake Qi; Haiying Cheng; Xiaoyue Hu; Edward J Miller; Xiaohong Wu; Kerry S Russell; Nicole Mikush; Jiasheng Zhang; Lei Xiao; Robert S Sherwin; Lawrence H Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

6.  Contractions but not AICAR increase FABPpm content in rat muscle sarcolemma.

Authors:  Jacob Jeppesen; Peter Albers; Joost J Luiken; Jan F C Glatz; Bente Kiens
Journal:  Mol Cell Biochem       Date:  2009-01-14       Impact factor: 3.396

7.  Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle.

Authors:  James G Nickerson; Hakam Alkhateeb; Carley R Benton; James Lally; Jennifer Nickerson; Xiao-Xia Han; Meredith H Wilson; Swati S Jain; Laelie A Snook; Jan F C Glatz; Adrian Chabowski; Joost J F P Luiken; Arend Bonen
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

Review 8.  Fuel availability and fate in cardiac metabolism: A tale of two substrates.

Authors:  Florencia Pascual; Rosalind A Coleman
Journal:  Biochim Biophys Acta       Date:  2016-03-16

9.  Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria.

Authors:  Carley R Benton; Graham P Holloway; S E Campbell; Yuko Yoshida; Narendra N Tandon; Jan F C Glatz; Joost J J F P Luiken; Lawrence L Spriet; Arend Bonen
Journal:  J Physiol       Date:  2008-01-31       Impact factor: 5.182

10.  Protein-mediated Fatty Acid Uptake in the Heart.

Authors:  Adrian Chabowski; Jan Górski; Jan F C Glatz; Joost J F P Luiken; Arend Bonen
Journal:  Curr Cardiol Rev       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.